Volver a Agenda
S9 - Practical Implementation of Next-Generation Post-Marketing Safety Studies
Session Chair(s)
Min-Jung Lim, MPHARM, RPH
CEO & Senior Pharmacovigilance Consultant, MediSafe, Pharmacovigilance Services, Korea, Republic of
Seongsik Kang, MD
Senior Vice President, HANDOK, Inc, Korea, Republic of
Speaker(s)
Current Status of RWD-Based Safety Studies (Database Studies) in Japanese PMS
Director, Strategic Excellence Dept, RWD Solutions Div., CMIC Co., Ltd., Japan
Case Study : RWD-Based Safety Study in RMP – Korea
VP, Head of Medical Affairs, SK bioscience, Korea, Republic of
Practical Implementation of Next-Generation Post-Marketing Safety Studies From RMP Safety Questions to Practical RWD Study Design in Korea
Director, DreamCIS Inc., Korea, Republic of
Seung Hee Jeong, PHD
RWE Generation Team Lead, , Pfizer Korea, Korea, Republic of
Jung Ae Kim, PHD
Professor, Pharmacogenomics Research Center, Inje University, Korea, Republic of
So Hee Kim, PHD
Director / Ministry of Food and Drug Safety, National Institute of Food and Drug Safety Evaluation (NIFDS), Korea, Republic of
¿Tiene una cuenta?
